Survival in the pediatric end-stage renal disease (ESRD) population has improved substantially over recent decades. Nonetheless, mortality remains at least 30 times higher than that of healthy peers. Patient survival is multifactorial and dependent on various patient and treatment characteristics and degree of economic welfare of the country in which a patient is treated. In this educational review, we aim to delineate current evidence regarding mortality risk in the pediatric ESRD population and provide pediatric nephrologists with up-to-date information required to counsel affected families.
CITATION STYLE
Chesnaye, N. C., van Stralen, K. J., Bonthuis, M., Harambat, J., Groothoff, J. W., & Jager, K. J. (2018, April 1). Survival in children requiring chronic renal replacement therapy. Pediatric Nephrology. Springer Verlag. https://doi.org/10.1007/s00467-017-3681-9
Mendeley helps you to discover research relevant for your work.